Earningsreport

Q3/2024 9/30/2024 EPS -0.490 ZacksConsensus -0.570 ActVsEst 0.080 - Beat

Cocrystal Pharma, Inc.  (COCP) 
NASDAQ:AMEX Investor Relations: cocrystalpharma.com